Lifeward Ltd. LFWD

Q2 FY2026 · ended Jun 30, 2026 · Revenue $268,000, -95.3% YoY · Filed Aug 14, 2026

Lifeward Ltd. (LFWD) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $268,000 and a net loss of $11.5 million. Free cash flow was -$6.0 million. As of Jun 30, 2026 it held $9.4 million in cash and investments and $2.6 million in total debt.

Revenue
$268,000
-95.3% vs year-ago quarter
Net income
$-11.52M
-75.5% vs year-ago quarter
Operating cash flow
$-6.00M
-52.6% vs year-ago quarter
Free cash flow
$-6.01M
-52.8% vs year-ago quarter
EPS
$-4.12
+41.2% vs year-ago quarter
Dividend per share
None
Shares outstanding
2.83M
-82.0% vs year-ago quarter
Net cash
$6.89M
Q2 FY2026
Operating margin
263.1%
TTM

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
LFWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Hudson, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1607962
Former names
ReWalk Robotics Ltd. (until Sep 16, 2024); Argo Medical Technologies Ltd. (until May 16, 2014)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$268,000
$443,000
$200,000
$300,000
$5.7M
Operating income
-$4.2M
-$10.3M
-$5.1M
-$3.1M
-$6.6M
Net income
-$11.5M
-$10.8M
-$5.3M
-$3.2M
-$6.6M
Diluted EPS
-$4.12
-$6.70
$0.16
-$0.20
-$7.01
Operating cash flow
-$6.0M
-$3.7M
-$3.6M
-$3.8M
-$3.9M
Free cash flow
-$6.0M
-$3.7M
-$3.6M
-$3.8M
-$3.9M
Total assets
$35.0M
$33.4M
$22.9M
$23.2M
$26.8M
Total liabilities
$22.8M
$27.1M
$14.5M
$10.4M
$11.7M
Stockholders' equity
$12.2M
$6.3M
$8.4M
$12.8M
$15.1M
Cash and investments
$9.4M
$11.4M
$2.2M
$2.0M
$5.1M
Total debt
$2.6M
$1.5M
$1.6M
$237,000
$375,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 27, 2026 Oct 27, 2026
8-K Current report
Officer or director change
Oct 8, 2026 Oct 4, 2026
8-K Current report
Officer or director change
Oct 1, 2026 Oct 1, 2026
ARS Annual report to shareholders Sep 25, 2026 Sep 25, 2026
8-K Current report Sep 15, 2026 Sep 15, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.